PARIS, July 22, 2011 /PRNewswire/ -- Sanofi (EURONEXT : SAN ; NYSE : SNY) is pleased to announce today the appointment of Greg Irace, currently President and CEO of Sanofi's US operations, to the newly created role of Senior Vice President, Global Services. In his new role, Greg will lead the Global Information Systems function, be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared services. Greg will report to Jerome Contamine, Executive Vice President, Chief Financial Officer, and will continue to be a member of the Global Management Committee. He will be based in Bridgewater, New Jersey.
Jerome Contamine, Executive Vice President, Chief Financial Officer, Sanofi, commented: "The integration of Genzyme and Merial gives Sanofi the opportunity to create a platform of shared support functions to serve Sanofi's five North American businesses and its more than 20,000 employees. I am confident that Greg's dedication and the leadership he has shown in his previous roles will result in his leading this new organization to great success."
Anne C. Whitaker will join Sanofi as President, North America, Pharmaceuticals, effective September 1, 2011. She will report to Hanspeter Spek, President, Global Operations and will join the Global Management Committee. She will be based in Bridgewater, New Jersey.
Hanspeter Spek, President, Global Operations, Sanofi, declared: "The knowledge and experience Anne has gained through her previous roles in Sales, Marketing and Leadership Development in the Pharmaceutical industry, particularly in the United States, make her ideally suited to drive the renewed growth of our pharmaceutical operations in North America."
Anne joins Sanofi from GSK, where she was Senior Vice P
Copyright©2010 PR Newswire.
All rights reserved